AI Empowers Tumor Progression Evaluation and Supports Independent Imaging Review in Oncology Clinical Trials
Recently, Professor Zhangsheng Yu, the founder of Intelligent Medicine Original Medical Technology (Shanghai), led his team to collaborate with an international pharmaceutical company. Their research, titled “Deep learning for oncologic treatment outcomes and endpoints evaluation from CT scans in liver…